| 标题 |
Phase 3 Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: Long-Term Follow-Up of the GRIFFIN Study Ixazomib、来那度胺和地塞米松治疗新诊断多发性骨髓瘤患者的III期试验:GRIFFIN研究的长期随访
|
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)